trial
as of 2026-07-01The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
NCTId NCT00222833
at a glance
Phase 4 · Completed
Enrollment 30
Sponsored by University of Pittsburgh Medical Center
Primary completion 2005-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
30
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2004-10
Primary completion
2005-12
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of Pittsburgh Medical CenterLead Sponsor
Bristol-MyersCollaborator
Investigators
1
Rohan Ganguli, MDPrincipal Investigator
Sites
1 total
Pittsburgh, United States
Facts & assertions
4 sourced
Enrollment
30
Phase
PHASE4
Primary Completion Date
2005-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
company
indication
investigator
person